Antonia Cronin


Consultant nephrologist


Dr Antonia Cronin qualified in medicine from St Bartholomew’s and the Royal London School of Medicine in 1996. She completed her general medical training and obtained membership of the Royal College of Physicians of the United Kingdom (MRCP, UK) in 1999. Her specialist training in nephrology and transplantation included posts at Hammersmith Hospital, Charing Cross Hospital, and Guy's and St Thomas' NHS Foundation Trust. From 2006-2009 she was a Wellcome Trust Research Training Fellow with Professor Sir Robert Lechler at King’s College London, and Professor John Harris at the University of Manchester. She was appointed consultant nephrologist in April 2010.

Alongside her clinical expertise in nephrology and transplantation, Antonia has an internationally renowned portfolio of academic expertise in the field of organ donation and transplantation ethics and law. She completed an MA in Medical Law and Ethics at the Centre for Medical Law and Ethics, School of Law, King’s College, London in 2006, and received a distinction award. She obtained a PhD in Medical Law and Ethics in 2009 from the Institute for Science, Ethics and Innovation, at the School of Law, University of Manchester. In 2013 she was appointed honorary senior lecturer in organ donation and transplantation ethics at the MRC Centre for Transplantation, King's College London. She is a tutor at the Centre for Medical Law and Ethics at King’s and affiliate member of King's College Social Science, Health and Biomedicine, Ethics and Social Justice research group.

Antonia’s expertise in ethics and law has led to numerous public and professional appointments. From 2008-2016 she was a trustee of the Governing Body of the Institute of Medical Ethics (IME). From 2012-2016 she was appointed member of the UK Government's Donation Ethics Committee (UKDEC). During this appointment she contributed to numerous policies on organ donation ethics published by the Academy of Medical Royal Colleges. From 2008-2011 and from 2014-2018 she was Chair of the British Transplantation Society (BTS) Ethics Committee and BTS Council Member. In this role she organised and facilitated national symposia, conferences and industry sponsored events and worked alongside stakeholders to develop national guidelines and position statements. Since 2017 she has been a board member of the Ethical Legal and Psychological Aspects of Transplantation (ELPAT) group, which is a sub-section of the European Society of Transplantation (ESOT). She is co-chair of their Ethical and Legal Boundaries section.

She is currently a Honorary Reader in Medical Ethics and Law at King's College, London.

Education and training

  • FRCP (UK), 2016
  • PhD, 2010
  • MA (Distinction), 2006
  • MRCP (UK), 1999
  • MBBS (London), 1996
  • BSc (UCL), 1993

Research interests

The main focus of Dr Antonia Cronin's academic work is the ethical and legal analysis on matters raised by scientific research and clinical practice, in particular the regulation of organ donation and transplantation and the translation of its related research into clinical practice. Her work draws on interdisciplinary insights gained from science, medicine, social science, philosophical bioethics, public policy and the law.

She has been appointed expert reviewer for the European Council, the National Institute for Health Research (NIHR) and the Wellcome Trust. She regularly undertakes peer review for numerous academic journals including Transplantation, Transplant International, The Lancet, Medical Law Review, Journal of Medical Ethics, Bioethics, Nature Reviews Nephrology and The American Journal of Transplantation.

She is currently ethics advisor to several collaborative translational research consortia in receipt of over €15 million funding by the European Commission Horizon 2020 scheme. These include:

  • 2020-2025 VANGUARD New Generation Cell Therapy: Bioartificial Pancreas to Cure Type 1 Diabetes
  • 2019-2024 RESHAPE Consortium: Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches - from Advanced Technology Developments to First-in-Human Trials.
  • 2016-2020 ENCKEP: European Network for Collaboration on Kidney Exchange Programmes.
  • 2013-2019 BioDRIm Consortium: BIOmarker-DRiven personalised Immunosuppression in the implementation of biomarker driven strategies for personalising immunosuppression.

She sits on the advisory board of the MRC funded project ‘About Face’, the first interdisciplinary study of the affective and cultural history of face transplants, and the implications for innovative surgical practice.

Last updated: April 2022

Is this page useful?